Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery

Clinical trial NCT01533207 · TERMINATED

Trial details

NCT number

NCT01533207

Sponsor

Gynecologic Oncology Group

Status

TERMINATED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2012-06-04

Primary completion

2018-06-30

Enrollment

38

View on ClinicalTrials.gov